ALI REHMAN: Open Payments
NPI 1144906801 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 7 payments from 4 companies in 2025. Trend: 2023 $325 · 2024 $1,095 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $203 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Alkermes, Inc. | 1 | $16 |
Products named: REXULTI, COBENFY, INVEGA SUSTENNA, ARISTADA.
Industry payments across TX — which companies pay providers there.
